GSK3: a key target for the development of novel treatments for type 2 diabetes mellitus and Alzheimer disease
- 21 December 2011
- journal article
- review article
- Published by Walter de Gruyter GmbH in Progress in Neurobiology
- Vol. 23 (1), 1-11
- https://doi.org/10.1515/rns.2011.061